Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU Market Read more about Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU Market
Accuray Reports Fourth Quarter and Fiscal 2023 Financial Results Read more about Accuray Reports Fourth Quarter and Fiscal 2023 Financial Results
Accuray to Report Fiscal Year-End 2023 Financial Results on August 9, 2023 Read more about Accuray to Report Fiscal Year-End 2023 Financial Results on August 9, 2023
Accuray Incorporated Announces Its Addition to the Russell 2000® Index Read more about Accuray Incorporated Announces Its Addition to the Russell 2000® Index
Accuray Announces Suzanne Winter Selected as One of the Top 50 Healthcare Technology CEOs of 2023 Read more about Accuray Announces Suzanne Winter Selected as One of the Top 50 Healthcare Technology CEOs of 2023
Accuray CyberKnife® and TomoTherapy® Platforms Featured in More Than 55 Abstracts Presented at ESTRO 2023, Reinforcing Systems' Versatility, Efficiency and Effectiveness Read more about Accuray CyberKnife® and TomoTherapy® Platforms Featured in More Than 55 Abstracts Presented at ESTRO 2023, Reinforcing Systems' Versatility, Efficiency and Effectiveness
Accuray Reports Fiscal 2023 Third Quarter Financial Results Read more about Accuray Reports Fiscal 2023 Third Quarter Financial Results
Accuray to Report Third Quarter Fiscal 2023 Financial Results on April 26, 2023 Read more about Accuray to Report Third Quarter Fiscal 2023 Financial Results on April 26, 2023
Accuray Incorporated to Speak at 33rd Annual Oppenheimer Healthcare Conference Read more about Accuray Incorporated to Speak at 33rd Annual Oppenheimer Healthcare Conference
Accuray to Participate in the Cowen 43rd Annual Health Care Conference Read more about Accuray to Participate in the Cowen 43rd Annual Health Care Conference
